Skip to main content
GH
NASDAQ Life Sciences

$500M 0% Convertible Notes Priced at 35% Premium; Proceeds to Retire 2027 Notes

Tom Rudovsky · Reported by BusinessWire
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$155
Mkt Cap
$20.94B
52W Low
$74.55
52W High
$191.05
52W Position info
108% above low
Off High info
19% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

GH has more than doubled off its 52-week low of $74.55.

Summary

Guardant priced $500 million of 0% convertible senior notes due 2032 at a 35% conversion premium, implying an initial conversion price of about $208.95 versus the $154.78 last sale on November 11. The deal follows yesterday's launch announcement and adds the terms that matter: no coupon, a capped call with a $309.56 cap to blunt dilution, and an option for up to $50 million more. Net proceeds of roughly $489.3 million (about $538.3 million with the full option) go mainly to repurchasing about $395.2 million of the 2027 notes, with $51.7 million funding the capped call cost. The structure is a refinancing rather than fresh growth capital, and the zero coupon plus 35% premium points to solid demand. Watch the November 16 settlement and any hedging flows from the option counterparties, which the company flags could be substantial relative to average daily volume.

At the time of this announcement, GH was trading at $155.00 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $20.9B. The 52-week trading range was $74.55 to $191.05. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: BusinessWire.


Price Chart

Share this article

Copied!

GH - Latest Insights

GH
Nov 11, 2026, 4:17 PM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $154.78
Real-time Price: $155.00 info
Change: +$0.220 (+0.14%) info
Market Cap: $20.94B info
GH
Nov 05, 2026, 5:13 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $130.02
Real-time Price: $155.00 info
Change: +$24.98 (+19%) info
Market Cap: $20.94B info
GH
Nov 05, 2026, 4:05 PM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $159.34
Real-time Price: $155.00 info
Change: -$4.34 (-3%) info
Market Cap: $20.94B info
GH
Oct 08, 2026, 4:12 PM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $165.56
Real-time Price: $155.00 info
Change: -$10.56 (-6%) info
Market Cap: $20.94B info
GH
Sep 04, 2026, 3:44 PM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $156.46
Real-time Price: $155.00 info
Change: -$1.46 (-0.93%) info
Market Cap: $20.94B info